Experience

ProfoundBio Announces $1.8 Billion Acquisition by Genmab

April 3, 2024

Cooley advised ProfoundBio, a clinical-stage biotechnology company developing novel antibody-drug conjugate therapeutics for patients with cancer, on its definitive agreement to be acquired for $1.8 billion in an all-cash transaction by Genmab (NASDAQ: GMAB), a dual-listed, international biotechnology company that creates and develops differentiated antibody therapeutics to fight against cancer and other serious diseases.

Read more

Related contacts

Rama Padmanabhan
Partner, San Diego
Patrick Loofbourrow
Partner, Singapore
Rowook Park
Partner, San Diego
Ruomu Li
Partner, Shanghai
Jenny Ge
Associate, Los Angeles Santa Monica
Ross Eberly
Partner, Los Angeles Santa Monica
Megan Browdie
Partner, Washington, DC
Christopher Kimball
Partner, Washington, DC
Xander Lee
Partner, Los Angeles Santa Monica
Jamie Leigh
Partner, San Francisco
Izzy Lubarsky
Partner, New York
Barbara Mirza
Partner, Los Angeles Santa Monica
Sonia Nath
Partner, Washington, DC
Jean Park
Partner, New York
Lei Shen
Partner, Chicago
Stacey A. Bradford
Special Counsel, Washington, DC
Jeff Goldman
Special Counsel, Palo Alto
Amy Hallman Rice
Special Counsel, San Diego
Karen Tsai
Special Counsel, Washington, DC
Bin Wang
Special Counsel, Palo Alto
Andrew Bae
Associate, Washington, DC
Julia R. Brinton
Associate, Washington, DC
Megan Drill
Associate, San Diego
Mari Dugas
Associate, Washington, DC
Allison Kutner
Associate, New York
Joyce Li
Associate, Chicago
Jiqiang Lin
Associate, New York
Tyler McClure
Associate, San Francisco
Ivy Wang
Associate, Shanghai
Monica Xu
Counsel, Shanghai
Freddy Yip
Associate, Hong Kong
Zhijing Yu
Associate, Singapore
Andy Zachrich
Associate, San Diego
Letian Wei
Legal Consultant, Shanghai
Sherlyn Qu
Legal Consultant, Shanghai

Related Practices & Industries

SJ Semiconductor Signs $340 Million Series C+ Financing

April 12, 2023

Cooley advised SJ Semiconductor Corporation (SJSemi), a semiconductor foundry, on its $340 million Series C+ financing, with a post-money valuation of close to US$2 billion.

Related contacts

Ruomu Li
Partner, Shanghai
Wenlan Geng
Associate, Shanghai
Teresa Yang
Legal Consultant, Shanghai
Zixiang Liu
Associate, Shanghai
Sherlyn Qu
Legal Consultant, Shanghai

Related Practices & Industries

Admissions and credentials

California

New York

Rankings and accolades

Legal 500 Asia Pacific

  • Corporate and M&A in China – Leading Individual (2022-2024), Recommended Lawyer (2020-2021)
  • Private Equity in China – Next Generation Partner (2021-2024)
  • Life Sciences and Healthcare in China – Next Generation Partner (2022-2024) 
  • Real Estate and Constructions in China – Recommended Lawyer (2021)
  • Corporate (including M&A) in Hong Kong – Recommended Lawyer (2022)
  • Private Equity in Hong Kong – Recommended Lawyer (2022)

Chambers and Partners Greater China

  • Private Equity: Buyouts and Venture Investment – Ranked Lawyer (2021-2023)
  • Corporate and M&A – Ranked Lawyer (2023) 

IFLR1000 Asia Pacific Rankings

  • M&A in China  – Highly Regarded Lawyer (2022-2023)
  • Private Equity in China – Highly Regarded Lawyer (2022-2023)

IFLR1000 Women Leaders Award (2022-2023)